Form 6-K NYMOX PHARMACEUTICAL For: Jun 02

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of June, 2026

 

Commission File Number: 001-12033

 

Nymox Pharmaceutical Corporation

(Translation of registrant’s name into English)

 

Bay & Deveaux Streets, Nassau, The Bahamas 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒    Form 40-F ☐

 

  

On June 2, 2026, Nymox Pharmaceutical Corporation (the “Company”) issued a press release announcing that the Company's plans for Nymozarfex (TM) are currently focused on re-submission in the US for marketing approval; and it updated the drug reviews. This press release is furnished as Exhibit 99.1 to this report on Form 6-K and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

 

2

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Press Release of Nymox Pharmaceutical Corporation, dated June 2, 2026

 

3

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 3, 2026

 

	NYMOX PHARMACEUTICAL CORPORATION
	By:	/s/ Paul Averback
	Name:	Paul Averback
	Title:	President and Chief Executive Officer

 

4

 

---

ATTACHMENTS / EXHIBITS

PRESS RELEASE

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Venti’s Autonomous Vehicles Shatter 500,000-Mile and 340,000-Container Metrics in Global Logistics Hubs
• National Indie Excellence® Awards Announces 20th Annual Competition Results
• HubiFi and Rillet Partner to Make Daily Revenue Close a Reality for Modern Finance Operators